PROSION Therapeutics
Slim Chiha is a co-founder and CEO of PROSION Therapeutics, a position held since January 2019. Prior to this role, Slim Chiha served as a postdoctoral researcher on a BMBF-funded drug discovery project for cancer therapy from January 2018 to December 2019. In 2012, Slim Chiha worked as a research scientist at Bayer Pharmaceuticals. Slim Chiha earned a Doctorate in Natural Sciences (Dr. rer. nat.) in Organic Chemistry from the University of Cologne, completing this degree between 2014 and 2017, and also studied at the University of Oxford.
This person is not in any teams
PROSION Therapeutics
We are PROSION Therapeutics, a biotech & drug development company based in Germany that aims at making the undruggable druggable. Through our proprietary platform technology of LEGO-like chemical building blocks, we are able to develop new and effective drugs, targeting hard-to-treat diseases - starting with the most aggressive cancer forms.